Prosecution Insights
Last updated: November 04, 2026

Glaxosmithkline Intellectual Property (No 4) Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

The patent portfolio for Glaxosmithkline Intellectual Property (No 4) Ltd. is currently active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This prosecution is highly focused, involving 1 distinct examiner and 1 distinct art unit. Such a concentrated profile suggests that the current activity is limited to a specific invention or a narrow set of claims within the broader pharmaceutical field.

KIM, YUNSOO is the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because this is the only active matter, the examiner's individual review process and technical interpretation will be the sole determinants of the portfolio's immediate progress. The presence of 1 distinct art unit further simplifies the prosecution landscape, allowing practitioners to focus their arguments on the specific standards applied by KIM, YUNSOO in the Biotechnology & Pharmaceuticals sector. This concentration of effort is often beneficial for resolving complex technical issues with a point of contact at the USPTO.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, YUNSOO 1 66.1% +34.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17786251 IGG:TGFBETARII FUSION PROTEIN COMPOSITION KIM, YUNSOO —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17786251 IGG:TGFBETARII FUSION PROTEIN COMPOSITION KIM, YUNSOO —

Top Art Units

Art UnitApps
1641 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17786251 IGG:TGFBETARII FUSION PROTEIN COMPOSITION KIM, YUNSOO 1641 §103§112 Non-Final OA — Pending Jun 16, 2022

Managing Glaxosmithkline Intellectual Property (No 4) Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Glaxosmithkline Intellectual Property (No 4) Ltd. have?

Glaxosmithkline Intellectual Property (No 4) Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Glaxosmithkline Intellectual Property (No 4) Ltd. applications?

Yunsoo Kim has the most, with 1 of Glaxosmithkline Intellectual Property (No 4) Ltd.'s pending office actions.

What technology area are Glaxosmithkline Intellectual Property (No 4) Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month